We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$3.46B
Cap. Flow %
-1.41%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.64%
2 Healthcare 14.1%
3 Financials 12.4%
4 Consumer Discretionary 12.19%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
2626
DELISTED
Strongbridge Biopharma plc.
SBBP
$993K ﹤0.01%
+262,486
New +$787K
LEO
2627
BNY Mellon Strategic Municipals
LEO
$387M
$990K ﹤0.01%
127,525
– –
ASTH icon
2628
Astrana Health
ASTH
$1.77B
$990K ﹤0.01%
60,022
+2,322
+4% +$36.5K
RVI
2629
DELISTED
Retail Value Inc. Common Shares
RVI
$987K ﹤0.01%
869,843
+185,837
+27% +$210K
CZNC icon
2630
Citizens & Northern Corp
CZNC
$455M
$984K ﹤0.01%
47,646
-1,189
-2% -$22.4K
BWB icon
2631
Bridgewater Bancshares
BWB
$603M
$983K ﹤0.01%
95,932
– –
AVXL icon
2632
Anavex Life Sciences
AVXL
$310M
$980K ﹤0.01%
199,178
-12,512
-6% -$47.3K
PSNL icon
2633
Personalis
PSNL
$1.51B
$975K ﹤0.01%
75,114
+11,936
+19% +$132K
UFI icon
2634
UNIFI
UFI
$134M
$974K ﹤0.01%
75,613
-16,490
-18% -$195K
TISI icon
2635
Team
TISI
$77.7M
$973K ﹤0.01%
17,467
-9,438
-35% -$522K
AKTS
2636
DELISTED
Akoustis Technologies Inc
AKTS
$972K ﹤0.01%
117,310
+21,496
+22% +$166K
PZN
2637
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$954K ﹤0.01%
175,524
+8,591
+5% +$40.1K
PRVL
2638
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$948K ﹤0.01%
63,619
+13,889
+28% +$214K
EVC icon
2639
Entravision Communication
EVC
$1.1B
$946K ﹤0.01%
661,923
-13,233
-2% -$20.6K
ADMS
2640
DELISTED
Adamas Pharmaceuticals
ADMS
$945K ﹤0.01%
369,025
-111,112
-23% -$327K
TITN icon
2641
Titan Machinery
TITN
$445M
$942K ﹤0.01%
86,714
-62,066
-42% -$593K
SRGA
2642
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$933K ﹤0.01%
9,778
+1,342
+16% +$100K
VRAY
2643
DELISTED
ViewRay, Inc.
VRAY
$930K ﹤0.01%
415,223
+83,740
+25% +$179K
MCF
2644
DELISTED
Contango Oil & Gas Co.
MCF
$926K ﹤0.01%
+404,313
New +$987K
KRO icon
2645
KRONOS Worldwide
KRO
$989M
$924K ﹤0.01%
88,778
-3,148
-3% -$29.5K
MQY icon
2646
BlackRock MuniYield Quality Fund
MQY
$817M
$923K ﹤0.01%
61,305
– –
ACWX icon
2647
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
$921K ﹤0.01%
21,300
– –
SENEA icon
2648
Seneca Foods Class A
SENEA
$1.21B
$921K ﹤0.01%
27,233
+51
+0.2% +$1.79K
EIGR
2649
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$920K ﹤0.01%
3,195
-4,627
-59% -$1.36M
XBIT icon
2650
XBiotech
XBIT
$69.2M
$918K ﹤0.01%
67,013
+5,585
+9% +$78.5K
104 105
106
107 108

Similar funds

Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.